Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Professional, Health Care
NCT06279728: Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients	Available	N/A		Europe, Canada, US	Datopotamab deruxtecan, Dato-DXd, DS-1062a	Daiichi Sankyo, AstraZeneca	Advanced Non-Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer
NCT06099639: Medical Access Program for Patritumab Deruxtecan	Available	N/A		US	HER3-DXd, U3-1402	Daiichi Sankyo	Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer